REZUROCK
Kadmon Pharmaceuticals, LLC
Mark For: REZUROCK® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88401751 |
| Registration Number | 6654082 |
| Mark Literal Elements | REZUROCK |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | INTENT TO USE SECTION 2020-04-21 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Michael J. Leonard |
| Attorney Docket Number | 163761.00545 |
| Law Office Assigned | L70 |
| Employee Name | DUBOIS, MICHELLE E |
Timeline
| 2019-04-25 | Application Filed |
| 2019-07-16 | Location: TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED |
| 2019-07-16 | Status: Live/Pending |
| 2019-10-25 | Transaction Date |
| 2020-02-25 | Published |
| 2020-04-21 | Location: INTENT TO USE SECTION |
| 2020-04-21 | Status: Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six |
| 2022-02-22 | Trademark Registered |
Trademark Parties (Applicants & Owners)
| Party: |  Kadmon Pharmaceuticals, LLC |
| Address | 119 Commonwealth Drive Warrendale, PENNSYLVANIA UNITED STATES 15086 |
| Legal Entity Type | Limited Liability Company |
| Legal Entity State | PENNSYLVANIA |
Documents
 Drawing | JPEG | 2019-04-25 |
 TEAS RF New Application | MULTI | 2019-04-25 |
| XSearch Search Summary | XML | 2019-07-09 |
| Offc Action Outgoing | XML | 2019-07-16 |
| Response to Office Action | XML | 2020-01-15 |
| Amendment and Mail Process Complete | MULTI | 2020-01-17 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2020-01-24 |
| Notice of Publication | XML | 2020-02-05 |
| Notification Of Notice of Publication | XML | 2020-02-05 |
| OG Publication Confirmation | APPLICATION/XML | 2020-02-25 |
| Notice of Allowance | APPLICATION/XML | 2020-04-21 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceuticals and pharmaceutical preparations, namely, Anti-infectives, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, antifungal preparations, antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; pharmaceutical preparations and pharmaceutical agents for the treatment of Wilson's disease
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | pharmaceutical preparations and pharmaceutical agents |
| GS0051 | Pharmaceuticals and pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical products for the prevention and treatment of respiratory diseases |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-04-21 | |
| PUBLISHED FOR OPPOSITION | 2020-02-25 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-02-25 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-02-05 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-01-23 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-01-16 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-01-15 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-01-15 | 88889 |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-07-16 | 6325 |
| NON-FINAL ACTION WRITTEN | 2019-07-16 | 78353 |
| NON-FINAL ACTION E-MAILED | 2019-07-16 | 6325 |
| ASSIGNED TO EXAMINER | 2019-07-08 | 78353 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-05-10 | |
| NEW APPLICATION ENTERED IN TRAM | 2019-04-29 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 REZUROCK 90071349 not registered Live/Pending |
Kadmon Pharmaceuticals, LLC 2020-07-24 |
 REZUROCK 88401751 not registered Live/Pending |
Kadmon Pharmaceuticals, LLC 2019-04-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 